NEW YORK (GenomeWeb News) — Great Basin said today that it has secured $9.5 million in Series B funding.

The Salt Lake City-based company will use the funding to expand manufacturing and fund research and development, including further developing and expanding the test menu for its Portrait Analyzer molecular diagnostics platform.

Great Basin said that it will also use the funds to expand global commercialization efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.